Veracyte Inc reports results for the quarter ended in December - Earnings Summary

Veracyte

22/02/2023 22:02

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 5
cents​​ per share for the quarter ended in December. The mean
expectation of nine analysts for the quarter was for a loss
of 15 cents per share.
    * Revenue rose 19.2% to $80.30 million from a year ago;
analysts
expected $74.91 million. 
    * Veracyte Inc's reported EPS for the quarter was a loss
of 5
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Veracyte Inc shares had fallen by 4.3% this quarter.
    * The company reported a quarterly loss of $3.84 million.
    * Wall Street's median 12-month price target for Veracyte
Inc is
$33.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
22 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.05          Beat
 Sep. 30 2022      -0.25          -0.12          Beat
 Jun. 30 2022      -0.22          -0.13          Beat
 Mar. 31 2022      -0.24          -0.20          Beat